BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 33123996)

  • 1. Wnt Signaling in the Tumor Microenvironment.
    Ruan Y; Ogana H; Gang E; Kim HN; Kim YM
    Adv Exp Med Biol; 2021; 1270():107-121. PubMed ID: 33123996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
    Li X; Xiang Y; Li F; Yin C; Li B; Ke X
    Front Immunol; 2019; 10():2293. PubMed ID: 31616443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
    Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
    Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
    Patel S; Alam A; Pant R; Chattopadhyay S
    Front Immunol; 2019; 10():2872. PubMed ID: 31921137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells of the tumor microenvironment speak the Wnt language.
    Katanaev VL; Baldin A; Denisenko TV; Silachev DN; Ivanova AE; Sukhikh GT; Jia L; Ashrafyan LA
    Trends Mol Med; 2023 Jun; 29(6):468-480. PubMed ID: 37045723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies.
    Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X
    Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-3a-activated human fibroblasts promote human keratinocyte proliferation and matrix destruction.
    Sobel K; Tham M; Stark HJ; Stammer H; Prätzel-Wunder S; Bickenbach JR; Boukamp P
    Int J Cancer; 2015 Jun; 136(12):2786-98. PubMed ID: 25403422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing activation of WNT beta-catenin pathway in diverse landscape of endometrial carcinogenesis.
    De P; Aske JC; Dale A; Rojas Espaillat L; Starks D; Dey N
    Am J Transl Res; 2021; 13(11):12168-12180. PubMed ID: 34956444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights.
    Yuan Y; Wu D; Hou Y; Zhang Y; Tan C; Nie X; Zhao Z; Hou J
    Biochem Pharmacol; 2024 May; 223():116154. PubMed ID: 38513742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
    Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
    Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
    López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
    J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor microenvironment: promising therapeutic target].
    Kawasaki Y; Akiyama T
    Nihon Rinsho; 2015 Aug; 73(8):1283-7. PubMed ID: 26281679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic therapy to normalize the tumor microenvironment.
    Hauge A; Rofstad EK
    J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions.
    Le PN; Keysar SB; Miller B; Eagles JR; Chimed TS; Reisinger J; Gomez KE; Nieto C; Jackson BC; Somerset HL; Morton JJ; Wang XJ; Jimeno A
    Mol Carcinog; 2019 Mar; 58(3):398-410. PubMed ID: 30378175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment.
    Mun JY; Leem SH; Lee JH; Kim HS
    Front Immunol; 2022; 13():864739. PubMed ID: 35464435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wnt signaling pathway in cancer.
    Duchartre Y; Kim YM; Kahn M
    Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling.
    Tao B; Song Y; Wu Y; Yang X; Peng T; Peng L; Xia K; Xia X; Chen L; Zhong C
    Aging (Albany NY); 2021 Feb; 13(4):5284-5296. PubMed ID: 33535177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/beta-catenin pathway: modulating anticancer immune response.
    Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
    J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.